Related references
Note: Only part of the references are listed.Conversion from enzyme-inducing antiepileptic drugs to topiramate: Effects on lipids and c-reactive protein
Scott Mintzer et al.
EPILEPSY RESEARCH (2012)
Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial
Patrick Kwan et al.
LANCET NEUROLOGY (2011)
Effects of Antiepileptic Drugs on Lipids, Homocysteine, and C-Reactive Protein
Scott Mintzer et al.
ANNALS OF NEUROLOGY (2009)
Quantifying the response to antiepileptic drugs
Yitzhak Schiller et al.
NEUROLOGY (2008)
Results of treatment changes in patients with apparently drug-resistant chronic epilepsy
Anna L. Luciano et al.
ANNALS OF NEUROLOGY (2007)
Likelihood of seizure remission in an adult population with refractory epilepsy
Brian C. Callaghan et al.
ANNALS OF NEUROLOGY (2007)
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial
Anthony G. Marson et al.
LANCET (2007)
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy
M. J. Brodie et al.
NEUROLOGY (2007)
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy
MD Privitera et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
How long does it take for partial epilepsy to become intractable?
AT Berg et al.
NEUROLOGY (2003)
Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents
C Zona et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2001)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
